Navigation Links
ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer
Date:12/8/2009

EDINA, Minn., Dec. 8 /PRNewswire/ -- ARKRAY, Inc., a global leader of human and veterinary in vitro diagnostic instruments and reagents today announced an exclusive distribution agreement with scil animal care company for the SPOTCHEM(TM) EZ Chemistry Analyzer. Scil is a global organization focused on providing high quality veterinary diagnostic equipment.

Scil's first order of business will be to re-introduce the SPOTCHEM(TM) EZ, a small bench top chemistry analyzer, to the North American veterinary industry. Other veterinary-use products from ARKRAY will follow.

More than 8,500 SPOTCHEM(TM) EZ Chemistry Analyzers have been sold globally since 2000. The SPOTCHEM(TM) EZ is a compact, bench-top analyzer that enables easy, on-the-spot testing at veterinary clinics of various sizes. The analyzer can run a panel, a single test, or a combination so veterinarians can test the way they need to without wasting unnecessary tests. The system accepts whole blood or serum samples and has a built-in centrifuge. Results are available within 8 to 15 minutes to facilitate quick diagnosis and treatment.

"We're very excited about our new partnership and look forward to launching other veterinary-use products with scil," said Jonathan Chapman, President of ARKRAY, USA.

About ARKRAY USA

ARKRAY is a global leader of high-quality, cost-effective products that are simple, convenient, and easy-to-use, including blood glucose meters, test strips, safety lancets, as well as urine and clinical chemistry products. ARKRAY invests heavily in R&D and has a strong commitment to high-quality products. For patients, this means access to cutting-edge, reliable products without sacrificing quality, and exceptional customer service.

For more information about the SPOTCHEM EZ visit www.arkraypoc.com

About scil animal care company:

Scil animal care company is a global organization dedicated to delivering animal health professionals high quality diagnostic equipment. We understand that high quality products are not enough in today's modern veterinary laboratory. Post-acquisition in-hospital training, support and service make the critical difference to the ongoing performance of the instrument as well as its financial contribution to the veterinary practice.

SOURCE ARKRAY USA


'/>"/>
SOURCE ARKRAY USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System
2. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
3. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
4. CompuCyte Announces the Release of Four-Laser Imaging Cytometers
5. Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
6. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
7. ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program
8. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
9. CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition
10. Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference
11. Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
(Date:5/3/2016)... , May 4, 2016 ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved ... are expected to be developed in coming years. Many ... techniques. Cancer stem cell therapies are also expected to ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, ... contracted rheumatic fever, which damaged his heart. He continued ... But by June 2013, Shepherd,s heart was giving out ... death. On June 20, 2013, the Mesa, ... Artificial Heart (TAH-t). Like a heart transplant, the SynCardia ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... 2016 , ... Fertility Centers of New England announced today the opening of ... Center provides convenient access to care for patients seeking fertility treatment in Maine. “We ... Comprehensive Care in Portland,” said Fertility Centers of New England President and CEO, Joseph ...
(Date:5/4/2016)... ... 2016 , ... Vasont Systems, a top component content management ... the latest release of Adobe FrameMaker, Release 2015. The integration of the Vasont® ... editing and storing XML. , The VUI creates a smooth continued ...
(Date:5/3/2016)... Minnesota (PRWEB) , ... May 04, 2016 , ... ... more than 40 national and global construction firms representing the Construction Industry Safety ... have joined forces with one purpose: to inspire everyone in the industry to ...
(Date:5/3/2016)... Garden City, NY (PRWEB) , ... May 04, 2016 , ... ... as a 2016-2017 inductee into its VIP Woman of the Year Circle. She ... leading networking organization exclusively for professional women, boasting more than 850,000 members and over ...
(Date:5/3/2016)... CA (PRWEB) , ... May 03, 2016 , ... ... on Denver Business Journal, patients report dissatisfaction with numerous issues related to medical ... personnel, issues with billing, and poor bedside manner from hospital staff. Commenting on ...
Breaking Medicine News(10 mins):